43 results · 7ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Brand Name: Galaxy System Product Name: Galaxy System Model/Catalog Number: GAL-001 Product Description: The Galaxy SystemTM and its accessories are intended to provide bronchoscopic visualization of and access to patient airways for diagnostic and therapeutic procedure.

FDA Enforcement
Class II ·Ongoing·Noah Medical Corporation·December 3, 2025

IM Abbott Alinity ci-series (abdicqii) accessory driver v8.00.0001 software product that can receive information from a hospital computer system (also called a Laboratory Information System [LIS]).

FDA Enforcement
Class II ·Terminated·Data Innovations, LLC·October 31, 2018

Future Diagnostics STAT-IntraOperative-Intact-PTH (STAT-IO-I-PTH) Immunoassay kit REF 4K-IPT-00. in vitro diagnostic.

FDA Enforcement
Class II ·Ongoing·Future Diagnostics Solutions B.V.·February 1, 2023

TSX-IOI: AQUILION 32/64; System, X-Ray, Tomography, Computed. Designed to produce cross-sectional images of a human body.

FDA Enforcement
Class II ·Terminated·Toshiba American Medical Systems Inc·April 17, 2013

Moog Curlin Infusion, Ambulatory Infusion Pump The Curlin Ambulatory Infusion System includes Curlin Ambulatory multi-therapy and PainSmart pumps. Curlin 4000, catalog number 340; Curlin 6000, 6000 CMS, and PainSmart IOD, catalog number 360; and Curlin Pump Calibration Set, catalog number 340-4038.

FDA Enforcement
Class II ·Terminated·MOOG Medical Devices Group·February 17, 2016

Product Name: STAAR ICL Calculation Software Software Version: Version 8.00 Product Description: The STAAR ICL Calculation Software is designed as an aide in the calculation of the size and diopter power (with residual refraction) for physician selection of the lens. For toric ICLs, an Implantation Orientation Diagram (IOD) is also produced to provide the physician with pictorial representation of the axis of rotation and alignment. Note: The STAAR ICL Calculation Software resides on STAAR Surgical's e-commerce website in STAAR ICL planning support (Stella), as referenced in the attached recall communication. Component: No

FDA Enforcement
Class II ·Ongoing·Staar Surgical AG·June 24, 2026

IBA Proton Therapy System - PROTEUS 235

FDA Enforcement
Class II ·Ongoing·Ion Beam Applications S.A.·March 18, 2026

IBA Proton Therapy System - PROTEUS 235 ProteusPLUS and ProteusONE Software versions: PTS-8 versions, PTS-10 versions, PTS-11 versions, and PTS-12 versions

FDA Enforcement
Class II ·Ongoing·Ion Beam Applications S.A.·September 18, 2024

IBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

FDA Enforcement
Class II ·Ongoing·Ion Beam Applications S.A.·June 12, 2024

Proteus 235 Proton Therapy System Legacy Software version 7.2.7 and higher, models 110, 112, 113, and 116. Proton therapy

FDA Enforcement
Class II ·Terminated·Ion Beam Applications S.A.·April 30, 2014

Proton therapy system -Proteus 235 aka Proteus Plus. A medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

FDA Enforcement
Class II ·Terminated·Ion Beam Applications S.A.·May 24, 2017

Proteus 235, Proton Therapy System

FDA Enforcement
Class II ·Terminated·Ion Beam Applications S.A.·April 26, 2017

Proteus 235, Version PTS-11.0.1.2 and PTS-11.0.2 Product Usage: A device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

FDA Enforcement
Class II ·Terminated·Ion Beam Applications S.A.·July 18, 2018

Proteus 235, Universal Nozzle with snout 300x400; PBS dedicated nozzle with snout XL Product Usage: Device is designed to produce and deliver proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to the head and neck.

FDA Enforcement
Class II ·Terminated·Ion Beam Applications S.A.·July 25, 2018

Proteus 235, Pencil Beam Scanning version PTS-6.4.11.X The Proton Therapy System - Proteus 235 (brand names: Proteus Plus and Proteus ONE) is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to the head and neck.

FDA Enforcement
Class II ·Terminated·Ion Beam Applications S.A.·March 14, 2018

Proteus ONE and Proteus Plus

FDA Enforcement
Class II ·Terminated·Ion Beam Applications S.A.·June 20, 2018

adaPT insight (12C), v1.3.2, PAT.109 (US), Treatment room 4: I2C is used with a charged particle or photon radiation therapy system for localization of the patient position with respect to the therapy equipment and to provide correction feedback to the radiation therapy device.

FDA Enforcement
Class II ·Terminated·Ion Beam Applications S.A.·December 31, 2014

Proteus 235 Proton Therapy System for cancer treatment.

FDA Enforcement
Class II ·Terminated·Ion Beam Applications S.A.·November 5, 2014

Proteus 235

FDA Enforcement
Class II ·Terminated·Ion Beam Applications S.A.·April 5, 2017

Proteus 235, Proton Therapy System Product Usage: The Proton Therapy System - Proteus 235 is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to the head and neck.

FDA Enforcement
Class II ·Terminated·Ion Beam Applications S.A.·July 12, 2017